Cellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 8, 2004, Pages 2853-2860

  Van Bambeke, Françoise ^a   Carryn, Stéphane ^a,b   Seral, Cristina ^a,c   Chanteux, Hugues ^a   Tyteca, Donatienne ^a   Mingeot Leclercq, Marie Paule ^a   Tulkens, Paul M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF ARIZONA   (United States)

^c HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CHLOROQUINE; HORSERADISH PEROXIDASE; MONENSIN; ORITAVANCIN; OXYTETRACYCLINE; VANCOMYCIN;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL CULTURE; CELL STRAIN CACO 2; CENTRIFUGATION; DRUG SCREENING; DRUG UPTAKE; ENDOCYTOSIS; FIBROBLAST; FRACTIONATION; LISTERIA MONOCYTOGENES; LYSOSOME; MACROPHAGE; MOUSE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; COLONY COUNT, MICROBIAL; GLYCOPEPTIDES; HORSERADISH PEROXIDASE; LISTERIA MONOCYTOGENES; LYSOSOMES; MACROPHAGES; MICE; STAPHYLOCOCCUS AUREUS; SUBCELLULAR FRACTIONS; VANCOMYCIN;

EID: 3342953635     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.8.2853-2860.2004     Document Type: Article

References (46)

1. Allen, N. E., J. N. Hobbs, Jr., and T. I. Nicas. 1996. Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semi-synthetic glycopeptide antibiotic. Antimicrob. Agents Chemother. 40:2356-2362.
2. Baltch, A. L., R. P. Smith, W. J. Ritz, and L. H. Bopp. 1998. Comparison of inhibitory and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faecium. Antimicrob. Agents Chemother. 42:2564-2568.
3. Beauchamp, D., P. Gourde, M. Simard, and M. G. Bergeron. 1992. Subcellular localization of tobramycin and vancomycin given alone and in combination in proximal tubular cells, determined by immunogold labeling. Antimicrob. Agents Chemother. 36:2204-2210.
4. Carlier, M. B., I. Garcia-Luque, J. P. Montenez, P. M. Tulkens, and J. Piret. 1994. Accumulation, release and subcellular localization of azithromycin in phagocytic and non-phagocytic cells in culture. Int. J. Tissue React. 16:211-220.
5. Carlier, M. B., A. Zenebergh, and P. M. Tulkens. 1987. Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells. J. Antimicrob. Chemother. 20(Suppl. B):47-56.
6. Carlone, N. A., A. M. Cuffini, M. Ferrero, V. Tullio, and G. Avetta. 1989. Cellular uptake, and intracellular bactericidal activity of teicoplanin in human macrophages. J. Antimicrob. Chemother. 23:849-859.
7. Chanteux, H., M. P. Mingeot-Leclercq, E. Sonveaux, F. Van Bambeke, and P. M. Tulkens. 2003. Intracellular accumulation and activity of ampicillin used as free drug and as its phthalimidomethyl or pivaloyloxymethyl ester (pivampicillin) against Listeria monocytogenes in J774 macrophages. J. Antimicrob. Chemother. 52:610-615.
8. Chanteux, H., I. Paternotte, M. P. Mingeot-Leclercq, R. Brasseur, E. Sonveaux, and P. M. Tulkens. 2003. Cell handling, membrane-binding properties, and membrane-penetration modeling approaches of pivampicillin and phthalimidomethylampicillin, two basic esters of ampicillin, in comparison with chloroquine and azithromycin. Pharm. Res. 20:624-631.
9. Cooper, R. D., N. J. Snyder, M. J. Zweifel, M. A. Staszak, S. C. Wilkie, T. I. Nicas, D. L. Mullen, T. F. Butler, M. J. Rodriguez, B. E. Huff, and R. C. Thompson. 1996. Reductive alkylation of glycopeptide antibiotics: synthesis and antibacterial activity. J. Antibiot. (Tokyo) 49:575-581.
10. Cupers, P., A. Veithen, A. Kiss, P. Baudhuin, and P. J. Courtoy. 1994. Clathrin polymerization is not required for bulk-phase endocytosis in rat fetal fibroblasts. J. Cell Biol. 127:725-735.
11. Decorti, G., N. Malusa, G. Furlan, L. Candussio, and F. B. Klugmann. 1999. Endocytosis of gentamicin in a proximal tubular renal cell line. Life Sci. 65:1115-1124.
12. de Duve, C., T. de Barsy, B. Poole, A. Trouet, P. Tulkens, and F. Van Hoof. 1974. Lysosomotropic agents. Biochem. Pharmacol. 23:2495-2531.
13. El Mouedden, M., G. Laurent, M. P. Mingeot-Leclercq, and P. M. Tulkens. 2000. Gentamicin-induced apoptosis in renal cell lines and embryonic rat fibroblasts. Toxicol. Sci. 56:229-239.
14. Garcia, I., A. Pascual, S. Ballesta, and E. J. Perea. 2000. Uptake and intracellular activity of ofloxacin isomers in human phagocytic and nonphagocytic cells. Int. J. Antimicrob. Agents 15:201-205.
15. Harland, S., S. E. Tebbs, and T. S. Elliott. 1998. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin. J. Antimicrob. Chemother. 41:273-276.
16. Lowdin, E., I. Odenholt, and O. Cars. 1998. In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 42:2739-2744.
17. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
18. Maderazo, E. G., S. P. Breaux, C. L. Woronick, R. Quintiliani, and C. H. Nightingale. 1988. High teicoplanin uptake by human neutrophils. Chemotherapy 34:248-255.
19. Montenez, J. P., F. Van Bambeke, J. Piret, R. Brasseur, P. M. Tulkens, and M. P. Mingeot-Leclercq. 1999. Interactions of macrolide antibiotics (erythromycin A, roxithromycin, erythromycylamine [dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models. Toxicol. Appl. Pharmacol. 156:129-140.
20. Mukherjee, S., R. N. Ghosh, and F. R. Maxfield. 1997. Endocytosis. Physiol. Rev. 77:759-803.
21. Nicas, T. I., M. L. Zeckel, and D. K. Braun. 1997. Beyond vancomycin: new therapies to meet the challenge of glycopeptide resistance. Trends Microbiol. 5:240-249.
22. Ohkuma, S., and B. Poole. 1978. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA 75:3327-3331.
23. Ouadrhiri, Y., B. Scorneaux, Y. Sibille, and P. M. Tulkens. 1999. Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. Antimicrob. Agents Chemother. 43:1242-1251.
24. Ouadrhiri, Y., Y. Sibille, and P. M. Tulkens. 1999. Modulation of intracellular growth of Listeria monocytogenes in human enterocyte Caco-2 cells by interferon-gamma and interleukin-6: role of nitric oxide and cooperation with antibiotics. J. Infect. Dis. 180:1195-1204.
25. Perantoni, A., and J. J. Berman. 1979. Properties of Wilms' tumor line (TuWi) and pig kidney line (LLC-PK1) typical of normal kidney tubular epithelium. In Vitro 15:446-454.
26. Rejman, J., V. Oberle, I. S. Zuhorn, and D. Hoekstra. 2004. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 377(Pt 1):159-169.
27. Renard, C., H. J. Vanderhaeghe, P. J. Claes, A. Zenebergh, and P. M. Tulkens. 1987. Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophages. Antimicrob. Agents Chemother. 31:410-416.
28. Schwenzer, K. S., C. H. Wang, and J. P. Anhalt. 1983. Automated fluorescence polarization immunoassay for monitoring vancomycin. Ther. Drug Monit. 5:341-345.
29. Seral, C., S. Carryn, P. M. Tulkens, and F. Van Bambeke. 2003. Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes of Staphylococcus aureus. J. Antimicrob. Chemother. 51:1167-1173.
30. Seral, C., J. M. Michot, H. Chanteux, M. P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke. 2003. Influence of P-glycoprotein inhibitors on the accumulation of macrolides in J774 murine macrophages. Antimicrob. Agents Chemother. 47:1047-1051.
31. Seral, C., F. Van Bambeke, and P. M. Tulkens. 2003. Quantitative analysis of the activity of antibiotics (gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, oritavancin [LY333328]) against intracellular Staphylococcus aureus in mouse J774 macrophages. Antimicrob. Agents Chemother. 47:2283-2292.
32. Silverstein, S. C., R. M. Steinman, and Z. A. Cohn. 1977. Endocytosis. Annu. Rev. Biochem. 46:669-722.
33. Snyderman, R., M. C. Pike, D. G. Fischer, and H. S. Koren. 1977. Biologic and biochemical activities of continuous macrophage cell lines P388D1 and J774.1. J. Immunol. 119:2060-2066.
34. Steinberg, T. H. 1994. Cellular transport of drugs. Clin. Infect. Dis. 19:916-921.
35. Steinman, R. M., J. M. Silver, and Z. A. Cohn. 1974. Pinocytosis in fibroblasts. Quantitative studies in vitro. J. Cell Biol. 63:949-969.
36. Tartakoff, A. M. 1983. Perturbation of vesicular traffic with the carboxylic ionophore monensin. Cell 32:1026-1028.
37. Trainer, D. L., T. Kline, F. L. McCabe, L. F. Faucette, J. Feild, M. Chaikin, M. Anzano, D. Rieman, S. Hoffstein, and D. J. Li. 1988. Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int. J. Cancer 41:287-296.
38. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26:171-176.
39. Tulkens, P., H. Beaufay, and A. Trouet. 1974. Analytical fractionation of homogenates from cultured rat embryo fibroblasts. J. Cell Biol. 63:383-401.
40. Tulkens, P., and A. Trouet. 1978. The uptake and intracellular accumulation of aminoglycoside antibiotics in lysosomes of cultured rat fibroblasts. Biochem. Pharmacol. 27:415-424.
41. Tyteca, D., P. Van Der Smissen, M. Mettlen, F. Van Bambeke, P. M. Tulkens, M. P. Mingeot-Leclercq, and P. J. Courtoy. 2002. Azithromycin, a lysosomotropic antibiotic, has distinct effects on fluid-phase and receptor-mediated endocytosis, but does not impair phagocytosis in J774 macrophages. Exp. Cell Res. 281:86-100.
42. Tyteca, D., P. Van Der Smissen, F. Van Bambeke, K. Leys, P. M. Tulkens, P. J. Courtoy, and M. P. Mingeot-Leclercq. 2001. Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase pinocytosis in cultured fibroblasts. Eur. J. Cell Biol. 80:466-478.
43. Van Bambeke, F., Y. Van Laethem, P. Courvalin, and P. M. Tulkens. 2004. Glycopeptide antibiotics: from conventional molecules to new derivatives. Pharmacological properties and clinical use. Drugs 64:913-936.
44. Van der Auwera, P., T. Matsumoto, and M. Husson. 1988. Intraphagocytic penetration of antibiotics. J. Antimicrob. Chemother. 22:185-192.
45. Wibo, M., and B. Poole. 1974. Protein degradation in cultured cells. II. The uptake of chloroquine by rat fibroblasts and the inhibition of cellular protein degradation and cathepsin B1. J. Cell Biol. 63:430-440.
46. Williams, D. H. 1996. The glycopeptide story-how to kill the deadly 'superbugs.' Nat. Prod. Rep. 13:469-477.